{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:47:29Z","timestamp":1791506849102,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/ki.2013.211","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T13:20:06Z","timestamp":1370438406000},"page":"1025-1033","source":"Crossref","is-referenced-by-count":119,"title":["Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor\u2013dependent idiopathic nephrotic syndrome"],"prefix":"10.1016","volume":"84","author":[{"given":"Pietro","family":"Ravani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ponticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fornoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Magnasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bodria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Caridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Belingheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Ghio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Merscher-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Edefonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Murtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Muruve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Scolari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian M.","family":"Ghiggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.211_bb0010","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0272-6386(00)70258-7","article-title":"Changing incidence of glomerular diseases in adults","volume":"35","author":"Braden","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.211_bb0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0140-6736(85)91387-X","article-title":"Long-term outcome for children with minimal-change nephrotic syndrome","volume":"1","author":"Trompeter","year":"1985","journal-title":"Lancet"},{"key":"10.1038\/ki.2013.211_bb0020","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.211_bb0025","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.clinthera.2004.09.012","article-title":"Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study","volume":"26","author":"Ghiggeri","year":"2004","journal-title":"Clin Ther"},{"key":"10.1038\/ki.2013.211_bb0030","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2215\/CJN.05691108","article-title":"Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children","volume":"4","author":"Kyrieleis","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.211_bb0035","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/00007890-199405150-00017","article-title":"Cyclosporine enhances the synthesis of selected extracellular matrix proteins by renal cells \"in culture\". Different cell responses and phenotype characterization","volume":"57","author":"Ghiggeri","year":"1994","journal-title":"Transplantation"},{"key":"10.1038\/ki.2013.211_bb0040","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4049\/jimmunol.125.4.1678","article-title":"Characterization of a human B lymphocyte-specific antigen","volume":"125","author":"Stashenko","year":"1980","journal-title":"J Immunol"},{"key":"10.1038\/ki.2013.211_bb0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2567.2002.01495.x","article-title":"CD20-mediated apoptosis: signalling through lipid rafts","volume":"107","author":"Deans","year":"2002","journal-title":"Immunology"},{"key":"10.1038\/ki.2013.211_bb0050","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00001622-199811000-00012","article-title":"Use of rituximab, the new FDA-approved antibody","volume":"10","author":"Leget","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"10.1038\/ki.2013.211_bb0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMra0708875","article-title":"Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma","volume":"359","author":"Cheson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.211_bb0060","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s00467-005-2013-7","article-title":"Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome","volume":"20","author":"Nozu","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2013.211_bb0065","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc055495","article-title":"Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment","volume":"354","author":"Pescovitz","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.211_bb0070","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2011080775","article-title":"Rituximab in children with resistant idiopathic nephrotic syndrome","volume":"23","author":"Magnasco","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.211_bb0075","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","article-title":"Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases","volume":"23","author":"Guigonis","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2013.211_bb0080","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","article-title":"Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report","volume":"5","author":"Gulati","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.211_bb0085","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","article-title":"Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome","volume":"27","author":"Kemper","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.211_bb0090","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.211_bb0095","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1038\/ki.2013.211_bb0100","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00467-009-1195-9","article-title":"Fatal pulmonary fibrosis after rituximab administration","volume":"24","author":"Chaumais","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2013.211_bb0105","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","article-title":"Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project","volume":"10","author":"Carson","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1038\/ki.2013.211_bb0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00856540","article-title":"Acute leucoencephalopathy during cyclosporin A therapy in a patient with nephrotic syndrome","volume":"8","author":"Shimizu","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2013.211_bb0115","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","article-title":"Fc gammaRIIIa-158V\/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L\/R\/H phenotype","volume":"90","author":"Koene","year":"1997","journal-title":"Blood"},{"key":"10.1038\/ki.2013.211_bb0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.beha.2011.02.009","article-title":"Rituximab resistance","volume":"24","author":"Rezvani","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1038\/ki.2013.211_bb0125","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1158\/1078-0432.CCR-07-1255","article-title":"Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression","volume":"14","author":"Olejniczak","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/ki.2013.211_bb0130","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1158\/1078-0432.CCR-08-1403","article-title":"Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphoma","volume":"15","author":"Terui","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/ki.2013.211_bb0135","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"10.1038\/ki.2013.211_bb0140","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4049\/jimmunol.182.1.416","article-title":"Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes","volume":"182","author":"Perosa","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/ki.2013.211_bb0145","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood-2004-01-0277","article-title":"Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains","volume":"104","author":"Bezombes","year":"2004","journal-title":"Blood"},{"key":"10.1038\/ki.2013.211_bb0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bbamcr.2005.09.001","article-title":"Ceramide-enriched membrane domains","volume":"1746","author":"Bollinger","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/ki.2013.211_bb0155","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1182\/blood-2006-04-014639","article-title":"The epitope recognized by rituximab","volume":"108","author":"Binder","year":"2006","journal-title":"Blood"},{"key":"10.1038\/ki.2013.211_bb0160","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2005-04-1769","article-title":"Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor","volume":"107","author":"Perosa","year":"2006","journal-title":"Blood"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815560699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815560699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T06:36:05Z","timestamp":1688279765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815560699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0085253815560699"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.211","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}